Sanofi Genzyme

Latest articles

3d
Lowell Sun
Mass. bio-pharma jobs, investments rose substantially in 2016wages, for an average salary of $138,768, according to the report. This year, t
Lowell Sun / Posted 3 days ago
wages, for an average salary of $138,768, according to the report. This year, the state's largest biopharma employer is Sanofi Genzyme, which has 5,000 employees, followed by Shire with 3,040 and Biogen with 2,443. Venture investment in... Read more
18d
Business Wire
KSQ Therapeutics Emerges with $76 Million in Financing to Pioneer High-Confidence Drug DevelopmentMeeker, MD, as Chief Executive Officer. Dr. Meeker most recently served as Head
Business Wire / Posted 18 days ago
Meeker, MD, as Chief Executive Officer. Dr. Meeker most recently served as Head of the Specialty Care Business Unit of Sanofi-Genzyme and previously was Chief Executive Officer and President of Genzyme, a Sanofi Company. He brings more than 20... Read more
18d
Boston Globe
Ex-Sanofi-Genzyme executive David Meeker to lead KSQ TherapeuticsDavid Meeker, who stepped down from the top job at Cambridge-based Sanofi-Genzy
Boston Globe / Posted 18 days ago
David Meeker, who stepped down from the top job at Cambridge-based Sanofi-Genzyme in June, is heading a new biotech that has received $76 million in financing and was founded by several of the most prominent names in life sciences. Meeker will be... Read more
22d
Business Wire
Frazier Healthcare Partners Adds Experienced Global Biotech and Pharma Executive Mark Barrett to Life Sciences Teaman Entrepreneur-in-Residence (EIR). Most recently, Mr. Barrett served as Global
Business Wire / Posted 22 days ago
an Entrepreneur-in-Residence (EIR). Most recently, Mr. Barrett served as Global Head of Strategy & Business Development at Sanofi Genzyme and was a member of the company’s executive leadership team responsible for managing Sanofi Genzyme’s global... Read more
30d
Market Watch
Alnylam shares surge 40% on drug results that may herald a new type of medicineof patisiran late this year. (Alnylam will commercialize the drug in the U.S.,
Market Watch / Posted 30 days ago
of patisiran late this year. (Alnylam will commercialize the drug in the U.S., Canada and Western Europe, while Sanofi’s Sanofi Genzyme business unit will commercialize it in other parts of the world.) The Wednesday news is a “big win for ALNY... Read more
30d
Business Wire
Alnylam and Sanofi Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathyto file its first New Drug Application in late 2017 and first Marketing Authori
Business Wire / Posted 30 days ago
to file its first New Drug Application in late 2017 and first Marketing Authorisation Application shortly thereafter. Sanofi Genzyme is currently preparing for regulatory filings for patisiran in Japan, Brazil and other countries, to begin in... Read more

In this news